Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Insulin Degludec 2.56 Mg (70 Percent ) And Insulin Aspart 1.05 Mg (30 Percent ), 100 Iu/Ml, 3 Ml Penfil (Ryzodeg Penfill 3 Ml)
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106600935 |
|
Reference Number |
99241142D |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | Jabalpur |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/022025/106600935/viewNitPdf_4858297.pdf |
| Start Date | February 06, 2025 17:56 |
| End Date |
Expired
12/02/2025
Expired 592 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Insulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg (30 percent ), 100 iu/ml, 3 ml penfil (ryzodeg penfill 3ml)
For complete deion and other details, please refer to tender
Read moreInsulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg (30 percent ), 100 iu/ml, 3 ml penfil (ryzodeg penfill 3ml)
For complete deion and other details, please refer to tender
Read moreInsulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg (30 percent ), 100 iu/ml, 3 ml penfil (ryzodeg penfill 3ml)
For complete deion and other details, please refer to tender
Read moreInsulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg (30 percent ), 100 iu/ml, 3 ml penfil (ryzodeg penfill 3ml)
For complete deion and other details, please refer to tender
Read moreInsulin degludec 2.56 mg (70 percent ) and insul [insulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg (30 percent ), 100 iu/ml, 3 ml penfil (ryzodeg penfill 3ml)]
For complete deion and other details, please refer to tender
Read moreInsulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg .
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreInsulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70 percent soluble insulin degludec and 30 percent soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 mg salt-free anhydrous insulin aspart in 3 ml prefilled pen
For complete deion and other details, please refer to tender
Read moreof your Industry type